EA201000161A1 - Синтетические поверхностно-активные пептиды легких - Google Patents

Синтетические поверхностно-активные пептиды легких

Info

Publication number
EA201000161A1
EA201000161A1 EA201000161A EA201000161A EA201000161A1 EA 201000161 A1 EA201000161 A1 EA 201000161A1 EA 201000161 A EA201000161 A EA 201000161A EA 201000161 A EA201000161 A EA 201000161A EA 201000161 A1 EA201000161 A1 EA 201000161A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peptides
synthetic surface
active lung
lung
active
Prior art date
Application number
EA201000161A
Other languages
English (en)
Other versions
EA023499B1 (ru
Inventor
Ян Йоханссон
Торе Карстедт
Бенгт Робертсон
Маурицио Дельканале
Original Assignee
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. filed Critical КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Publication of EA201000161A1 publication Critical patent/EA201000161A1/ru
Publication of EA023499B1 publication Critical patent/EA023499B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к аналогам пептидов природного поверхностно-активного белка SP-B и его применению в получении композиций для лечения или профилактики респираторного дистресс-синдрома (RDS) и других респираторных расстройств.
EA201000161A 2007-08-09 2008-07-17 Синтетические аналоги природного легочного сурфактантного белка sp-b и их применение EA023499B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07114083A EP2022798A1 (en) 2007-08-09 2007-08-09 Synthetic pulmonary surfactant peptides
PCT/EP2008/005842 WO2009018908A1 (en) 2007-08-09 2008-07-17 Synthetic pulmonary surfactant peptides

Publications (2)

Publication Number Publication Date
EA201000161A1 true EA201000161A1 (ru) 2010-08-30
EA023499B1 EA023499B1 (ru) 2016-06-30

Family

ID=39207936

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000161A EA023499B1 (ru) 2007-08-09 2008-07-17 Синтетические аналоги природного легочного сурфактантного белка sp-b и их применение

Country Status (14)

Country Link
US (1) US8148492B2 (ru)
EP (2) EP2022798A1 (ru)
JP (1) JP5441904B2 (ru)
KR (1) KR101516451B1 (ru)
CN (2) CN101827861A (ru)
AT (1) ATE503768T1 (ru)
AU (1) AU2008286026B2 (ru)
BR (1) BRPI0813619B1 (ru)
CA (1) CA2695805C (ru)
DE (1) DE602008005901D1 (ru)
EA (1) EA023499B1 (ru)
ES (1) ES2360976T3 (ru)
MX (1) MX2010001543A (ru)
WO (1) WO2009018908A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
BRPI0715317B1 (pt) 2006-10-13 2021-10-05 Chiesi Farmaceutici S.P.A. Surfactantes reconstituídos com propriedades aperfeiçoadas
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US9815869B2 (en) * 2012-02-09 2017-11-14 University Of Rochester SP-B and SP-C peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
WO2014079898A1 (en) 2012-11-21 2014-05-30 Chiesi Farmaceutici S.P.A. Reconstituted pulmonary surfactants
CN114437233A (zh) * 2020-11-06 2022-05-06 湖北健翔生物制药有限公司 一种多肽二聚体的定向合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69432313T2 (de) * 1993-12-08 2003-10-16 Mitsubishi Pharma Corp Neuartiges sythetisches Peptil, diese enthaltende Zusammensetzung und Arznei-Zusammensetzung und Arznei gegen das Atemnotsyndrom
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
DE19602332A1 (de) * 1996-01-24 1997-07-31 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung von pulverförmigen Lungensurfactant-Zubereitungen
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
CA2399757A1 (en) * 2000-02-16 2001-08-23 Northwestern University Polypeptoid pulmonary surfactants
FI20002177A0 (fi) 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
WO2008011559A2 (en) * 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties

Also Published As

Publication number Publication date
AU2008286026B2 (en) 2013-11-21
ES2360976T3 (es) 2011-06-10
BRPI0813619B1 (pt) 2021-06-22
CN108676088A (zh) 2018-10-19
EA023499B1 (ru) 2016-06-30
JP2010535721A (ja) 2010-11-25
ATE503768T1 (de) 2011-04-15
CN101827861A (zh) 2010-09-08
KR20100053551A (ko) 2010-05-20
EP2185588A1 (en) 2010-05-19
CA2695805A1 (en) 2009-02-12
JP5441904B2 (ja) 2014-03-12
DE602008005901D1 (de) 2011-05-12
CA2695805C (en) 2016-11-22
BRPI0813619A2 (pt) 2020-01-14
US20090075892A1 (en) 2009-03-19
EP2022798A1 (en) 2009-02-11
MX2010001543A (es) 2010-03-15
EP2185588B9 (en) 2012-03-21
US8148492B2 (en) 2012-04-03
WO2009018908A1 (en) 2009-02-12
EP2185588B1 (en) 2011-03-30
KR101516451B1 (ko) 2015-04-30
AU2008286026A1 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
UA103526C2 (ru) Воспроизведенный сурфактант, который содержит аналоги белков естественных сурфактантов sp-b и sp-c
EA201000161A1 (ru) Синтетические поверхностно-активные пептиды легких
CO6400235A2 (es) Tensiactivos reconstituidos que tienen propiedades mejoradas
BRPI0811320A2 (pt) Surfactantes reconstituídos com propriedades melhoradas
DK1877435T3 (da) Glucagon-lignende peptid 2 (GLP-2)-analoger
WO2009035540A3 (en) Analogues of exendin-4 and exendin-3
CY1113094T1 (el) Ανοσοσφαιρινες κατευθυνομενες εναντι nogo
DE602005019416D1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
BR112015009486A2 (pt) surfactante reconstituído, formulação farmacêutica, kit e uso de surfactante reconstituído
CL2011001977A1 (es) Compuestos derivados de triazolopiridina, inhibidores de proteinas cinasas activadas por mitogeno p38; composicion farmaceutica; y su uso para el tratamiento de neumonia eosinofilica cronica, asma, enfermedad pulmonar obstructiva cronica y sindrome de angustia respiratoria en adultos, entre otras enfermedades.
WO2013120058A3 (en) Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
HRP20041058B1 (hr) Poboljšanje smjese sintetskih lipida za pripravke tenzida za ponovno uspostavljanje
PE20030837A1 (es) Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales
RS20170169A1 (sr) Poboljšana rekonstituisana kompozicija sufraktanta koja sadrži analoge sufraktanta proteina b (sp-b) i surfaktanta proteina c (sp-c)
TH135738B (th) องค์ประกอบสารลดแรงตึงผิวที่ถูกสร้างใหม่ (reconstituted surfactant composition) ซึ่งถูกปรับปรุง ที่ประกอบด้วยแอนะล็อกส์ของโปรตีนของสารลดแรงตึงผิว b(sp-b) และโปรตีนของสารลดแรงตึงผิว c (sp-c)

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM